| ||
Oxford
Genetic and Structural Studies Highlight Novel Key Factors in Autoimmune Diseases
A research team led by scientists from Oxford University (including the Structural Genomics Consortium, the Botnar Research Centre, the Weatherall Institute of Molecular Medicine, the Wellcome Building for Molecular Physiology, and the australian Diamantina Institute in Brisbane), have successfully deciphered the molecular mechanism how an ER protease (ERAP1) functions in a key step in cellular immunity- the processing of peptide antigens that are presented to Major Histocompatibilty Complex 1 (MHC1) molecules.
SGC Workshop on BMP/TGF-β Signalling & Disease
Science, Art and Drug Discovery, a Personal Perspective
Dr. Simon Campbell
Former SVP for WW Discovery Pfizer
Richard Doll Building
Friday 16th September 2011
Molecular Mechanism of ABC Transporters in Adaptive Immunity and Viral Escape
Prof. Dr. Robert Tampé
Head of Cellular Biochemistry in the Institute of Biochemistry, Biocenter Goethe-Universität Frankfurt, Germany
Richard Doll Building
Thursday 25th August 2011
Biology-Oriented Synthesis (BIOS)
Dr. Herbert Waldmann
Max Planck Institute, Dortmund
Richard Doll Building
Thursday 11th August 2011
Targeting Lysine Acetylation in Cancer
Dr. James Bradner
Dana-Farber/Harvard Cancer Center
Richard Doll Building
Monday 20th June 2011
SCOP revisited: structure shortcuts to function predictions
Dr. Alexey Murzin
MRC lab. of Molecular Biology, Cambridge
Richard Doll Building
Thursday 26th May 2011
The imprint of codons on protein structure
Dr. Charlotte Deane
Dept. of Statistics, Univ. of Oxford
Richard Doll Building
Thursday 24th March 2011
Dynamic optics for microscopy and photonic engineering
Dr. Martin Booth
Dept.of Engineering Science, University of Oxford
Richard Doll Building
Thursday 17th February 2011